Tiny Stem Cell Companies Close in on Major Heart Disease Goals Tiny Stem Cell Companies Close in on Major Heart Disease Goals

The early hope that stem cell therapy would make the paralyzed walk, the blind see and cure diabetes have given way to a long list of failures, highlighted by early stem cell champion Geron Corp abandoning the field in 2011.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Internal Medicine News Source Type: news